<Record>
<Term>Tipelukast</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Anti-asthmatic Agent</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Adjuvant/Anti-asthmatic Agent/Tipelukast</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Anti-asthmatic Agent</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Adjuvant</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Tipelukast</BroaderTerm>
<Synonym>4-[6-acetyl-3-[3-[(4-acetyl-3-hydroxy-2-propylphenyl)sulfanyl]propoxy]-2-propylphenoxy]butanoic acid</Synonym>
<Synonym>KCA-757</Synonym>
<Synonym>MN-001</Synonym>
<Synonym>TIPELUKAST</Synonym>
<Synonym>Tipelukast</Synonym>
<Source>NCI Thesaurus</Source>
</Record>
